iShares Nasdaq US Biotechnology UCITS ETF (Acc)

PhysicalIndex replication
AccumulatingDistribution policy
0.35 %TER
£989.44M Fund size
246Number of positions
0.44 % TD
48.31 %Top 10 share
USDCurrency
5SRI

Diversification

Here you can find the number of holdings and the composition of the index constituents of the iShares Nasdaq US Biotechnology UCITS ETF (Acc).

Holdings258
Stock positions246
Bond positions0
Cash and other positions12
% of assets in top 10 positions48.31 %

Market capitalisation

Here you can see the percentage breakdown of the iShares Nasdaq US Biotechnology UCITS ETF (Acc) by market capitalisation. Market capitalisation reflects the current stock market value of a publicly listed company.

Very large0.69 %
Large35.22 %
Mid-cap30.92 %
Small22.74 %
Micro10.43 %

Portfolio metrics

These are the forecasts for the portfolio metrics as well as value and growth rates of the iShares Nasdaq US Biotechnology UCITS ETF (Acc).

Portfolio metrics (forecast)
Price-to-earnings ratio (P/E)
6.60
Price-to-book ratio (P/B)
4.44
Dividend yield
0.53 %
Price/cash flow ratio
13.22
Price/sales ratio
4.60
Value and growth rates (forecast)
Book value growth
-0.03 %
Cash flow growth
16.13 %
Hist. earnings growth
26.14 %
Long-term estimated earnings growth
6.50 %
Revenue growth
6.24 %

Equity investment style

The extraETF investment style box is a highly useful tool for portfolio construction. The box classifies the iShares Nasdaq US Biotechnology UCITS ETF (Acc) along the vertical axis by market capitalisation and along the horizontal axis by value and growth characteristics.

25.46 % 10.12 % 0.34 % 6.48 % 14.67 % 9.77 % 6.07 % 12.20 % 14.90 %
Large
35.92 %
Medium
30.92 %
Small
33.17 %
Market capitalisation
Value
38.01 %
Blend
36.98 %
Growth
25.01 %
Stock style
At 25.46 %, Value stocks with a large market capitalisation represent the largest portfolio share.

Risk metrics

Here you can find important risk metrics for the iShares Nasdaq US Biotechnology UCITS ETF (Acc).

Volatility
16.51 %
Max. drawdown
-3.33 %
Sharpe Ratio
1.82
Treynor Ratio
30.80 %
Information Ratio
0.10 %
Correlation to benchmark
99.11 %
Capture Ratio Up
104.92
Capture Ratio Down
123.36
Batting Average
58.33 %
Alpha
-2.17 %
Beta
1.09
R2
98.22 %
Benchmark
NASDAQ Biotechnology TR USD
As of
31 Oct 2026

Would you like to use this feature and unlock the full potential of your investments?

Register now on extraETF.com and get unlimited access to all data & features.
Create portfolios, watchlists and price alerts, and use our professional-grade investment analysis.

Sign up now

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.